(Q63413480)

1

0 references

Carlos Vilariño

2

0 references

Virginia Leiro

3

0 references

Diana Valverde

Archivos de Bronconeumologia

4

0 references

publication date

January 2008

0 references

published in

0 references

volume

44

0 references

issue

1

0 references

page(s)

29-34

0 references

cites work

Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Heterozygous germline mutations in BMPR2, encoding a TGF-beta receptor, cause familial primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Genetic basis of pulmonary arterial hypertension: current understanding and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Prognostic factors for survival in human immunodeficiency virus-associated pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Gross BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Bone morphogenetic proteins induce apoptosis in human pulmonary vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Bone morphogenetic protein-2 inhibits serum deprivation-induced apoptosis of neonatal cardiac myocytes through activation of the Smad1 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Signaling molecules in nonfamilial pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Cell-based gene transfer of vascular endothelial growth factor attenuates monocrotaline-induced pulmonary hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary endothelial cell proliferation and severe pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Monoclonal endothelial cells in appetite suppressant-associated pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Investigation of Second Genetic Hits at the BMPR2 Locus as a Modulator of Disease Progression in Familial Pulmonary Arterial Hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

BMPR2 mutations found in Japanese patients with familial and sporadic primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021

Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor

1 reference

https://api.crossref.org/works/10.1016%2FS1579-2129%2808%2960006-3

7 January 2021